🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Collecting and storing samples of blood and exhaled breath from ...
Status
Terminated
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00898209
The purpose of this study is to investigate the response rate of cetuximab ...
Status
Completed
Location
Asan Medical Center
Start Date
2008-03
Trial ID
NCT00637091
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2007-10
Trial ID
NCT00565968
RATIONALE: Studying samples of blood and tissue in the laboratory from pati...
Status
Completed
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2009-01
Trial ID
NCT00898378
The goal of this observational study is to compare the efficacy of advanced...
Status
Recruiting
Location
Seoul St. Mary Hospital
Start Date
2024-06-26
Trial ID
NCT06796517
This prospective cohort study aims to assess the utility of a panel of mole...
Status
Unknown
Location
MRC Cancer Unit
Start Date
2020-09-01
Trial ID
NCT04155242
RATIONALE: ONTAK may be able to help reduce the type of cells that prevent ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2005-09
Trial ID
NCT00425672
This phase I/II clinical trial is studying the side effects and best dose o...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2011-01
Trial ID
NCT01281865
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Status
Completed
Location
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
Start Date
2008-08-14
Trial ID
NCT00729612
This phase I/II trial studies the best dose and side effects of recombinant...
Status
Active Not Recruiting
Location
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Start Date
2016-12-22
Trial ID
NCT02955290